Fountain Life is a Consumer Longevity company founded in 2020 and based in Naples, United States. It has raised $108M in total funding, most recently a Series B in 2025.

Fountain Life launches BASE, a $595 annual membership offering 100+ blood biomarkers, a DEXA scan, and AI-assisted health insights.
An annual preventive-health membership centered on advanced diagnostics designed to detect disease at its earliest, most treatable stage. Members undergo whole-body and brain MRI, AI-enhanced imaging analysis, coronary CT angiography, advanced blood and biomarker panels, and genomic testing, combined into a personalized health and longevity plan delivered through the company's clinics. The offering targets affluent consumers seeking proactive screening, and the company has acquired health-data technology to power its diagnostics and membership services.